Literature DB >> 9570257

The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat.

W Fries1, E Pagiaro, E Canova, P Carraro, G Gasparini, F Pomerri, A Martin, C Carlotto, E Mazzon, G C Sturniolo, G Longo.   

Abstract

BACKGROUND: Reduced blood coagulability seems to protect against inflammatory bowel disease; pilot studies using heparin in patients with inflammatory bowel disease have reported positive results. AIM: To evaluate the effects of heparin treatment on microangiographic and on inflammatory parameters in experimental colitis, induced by trinitrobenzene sulphonic acid (TNBS)-ethanol.
METHODS: Four groups of rats: (i) controls (saline enema), TNBS-induced colitis with (ii) sham treatment (saline, s.c.), (iii) dexamethasone (0.25 mg/kg/day s.c.) and (iv) heparin (500 U/kg t.d.s., s.c.). Microangiography was performed 2 and 4 days after colitis induction. Partial thromboplastin time, colonic wet weight, macroscopic damage score and mucosal myeloperoxidase (MPO) activity were determined at day 4.
RESULTS: TNBS-induced colitis caused a reduction in visible bowel wall vessels, which was prevented by heparin (P < 0.05) but not by steroids. The macroscopic damage scores and colon wet weights were similar in all colitis groups. Compared to untreated colitis the MPO activity in heparin-treated animals was of borderline significance.
CONCLUSIONS: Heparin treatment improved microangiographic features and reduced inflammation to a certain degree. Steroids delayed development of colon hypoperfusion, but were ineffective on MPO activity. It remains to be determined if the observed effects are due to the antithrombotic activity of heparin or to an anti-inflammatory action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570257     DOI: 10.1046/j.1365-2036.1998.00293.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

1.  Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut.

Authors:  E Kankuri; K Vaali; R Korpela; I Paakkari; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

2.  Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat.

Authors:  T C Peterson; C E Cleary; A M Shaw; D A Malatjalian; S J Veldhuyzen van Zanten
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

3.  Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial.

Authors:  I Dotan; A Hallak; N Arber; M Santo; A Alexandrowitz; Y Knaani; R Hershkoviz; E Brazowski; Z Halpern
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

4.  Protective effects of black cumin (Nigella sativa) oil on TNBS-induced experimental colitis in rats.

Authors:  F Isik; Tugba Tunali Akbay; A Yarat; Z Genc; R Pisiriciler; E Caliskan-Ak; S Cetinel; A Altıntas; G Sener
Journal:  Dig Dis Sci       Date:  2010-07-24       Impact factor: 3.199

5.  Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes.

Authors:  Sheng-Li Ji; Hui-Fei Cui; Feng Shi; Yan-Qing Chi; Ji-Chao Cao; Mei-Yu Geng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 6.  The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Authors:  Essam Elsayed; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

Review 7.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

8.  Effects of low molecular weight heparin on platelet surface P-selectin expression and serum interleukin-8 production in rats with trinitrobenzene sulphonic acid-induced colitis.

Authors:  Bing Xia; Hong Han; Ke-Jian Zhang; Jin Li; Guang-Song Guo; Ling-Ling Gong; Xian-Chang Zeng; Jun-Yan Liu
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

9.  Efficacy of intracolonic administration of low-molecular-weight heparin CB-01-05, compared to other low-molecular-weight heparins and unfractionated heparin, in experimentally induced colitis in rat.

Authors:  Giuseppe Celasco; Luigi Moro; Roberta Bozzella; Katia Mangano; Cinzia Quattrocchi; Caterina Aiello; Marco Donia; Paolo Fagone; Roberto Di Marco
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

Review 10.  Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation.

Authors:  Hideo Yoshida; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.